Gkazi, SA;
Troakes, C;
Topp, S;
Miller, JW;
Vance, CA;
Sreedharan, J;
Al-Chalabi, A;
... Shaw, CE; + view all
(2019)
Striking phenotypic variation in a family with the P506S UBQLN2 mutation including amyotrophic lateral sclerosis, spastic paraplegia, and frontotemporal dementia.
Neurobiology of Aging
, 73
, Article 229. 10.1016/j.neurobiolaging.2018.08.015.
Preview |
Text (Article)
Gkazi_240718UBQLN2_ASG.pdf - Accepted Version Download (896kB) | Preview |
Preview |
Text (Figure 1)
Gkazi_Figure1.pdf - Accepted Version Download (838kB) | Preview |
Preview |
Text (Supplementary table 1)
Gkazi_Supplementary Table 1. Summary of all published UBQLN2 mutations.pdf - Accepted Version Download (867kB) | Preview |
Abstract
Analysis of 226 exome-sequenced UK cases of familial amyotrophic lateral sclerosis (ALS) and frontotemporal dementia identified 2 individuals who harbored a P497H and P506S UBQLN2 mutation, respectively (n = 0.9%). The P506S index case presented with behavioral variant frontotemporal dementia at the age of 54 years then progressed to ALS surviving 3 years. Three sons presented with (1) slowly progressive pure spastic paraplegia with an onset at 25 years and (2) ALS with disease onset of 25 years and survival of 2 years, and (3) ALS presenting symptoms at the age of 26 years, respectively. Analysis of postmortem tissue from the index case revealed frequent neuronal cytoplasmic UBQLN2-positive inclusions in the dentate gyrus and TDP-43-positive neuronal cytoplasmic inclusions in the frontal and temporal cortex and granular cell layer of the dentate gyrus of the hippocampus. Furthermore, a comprehensive analysis of published UBQLN2 mutations demonstrated that only proline-rich domain mutations contribute to a significantly earlier age of onset in male patients (p = 0.0026).
Type: | Article |
---|---|
Title: | Striking phenotypic variation in a family with the P506S UBQLN2 mutation including amyotrophic lateral sclerosis, spastic paraplegia, and frontotemporal dementia |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1016/j.neurobiolaging.2018.08.015 |
Publisher version: | http://doi.org/10.1016/j.neurobiolaging.2018.08.01... |
Language: | English |
Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
Keywords: | Familial amyotrophic lateral sclerosis (FALS), Spastic paraplegia (SP), Frontotemporal dementia (FTD), UBQLN2 |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Infection, Immunity and Inflammation Dept |
URI: | https://discovery.ucl.ac.uk/id/eprint/10063686 |
Archive Staff Only
View Item |